|
Delayed
Bombay S.E.
04:57:53 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 158.85 INR | 0.00% |
|
+2.65% | -6.61% |
| Market Cap | 505M 5.32M 4.59M 4.32M 3.93M 7.39M 7.43M 51.03M 19.86M 257M 19.97M 19.54M 852M | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 472M 4.98M 4.29M 4.04M 3.68M 6.92M 6.96M 47.75M 18.59M 240M 18.69M 18.29M 797M | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 week | +2.65% | ||
| Current month | +1.83% | ||
| 1 month | -7.43% | ||
| 3 months | -1.67% | ||
| 6 months | +25.77% | ||
| Current year | -6.61% |
| 1 week | 150 |  | 159.95 |
| 1 month | 150 | | 188 |
| Current year | 100.1 | | 188 |
| 1 year | 100.1 | | 220 |
| 3 years | 100.1 | | 398 |
| 5 years | 97.4 | | 398 |
| 10 years | 21.5 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 20/08/2016 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 06/10/2005 |
| Compliance Officer | - | 02/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 11/12/2005 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 06/10/2005 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 20/08/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +2.65% | -11.99% | -25.00% | 5.32M | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,034B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 654B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 459B | |
| -1.50% | -7.04% | +33.55% | +33.94% | 343B | |
| +6.25% | +2.04% | +28.97% | +46.57% | 307B | |
| -0.07% | -4.12% | +0.95% | +11.79% | 251B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 237B | |
| +0.51% | -4.52% | -19.50% | -54.83% | 202B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 186B | |
| Average | +1.45% | -2.46% | +25.19% | +43.14% | 367.16B | |
| Weighted average by Cap. | +1.63% | -3.38% | +38.40% | +66.45% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 340M 3.58M 3.09M 2.91M 2.65M 4.98M 5.01M 34.35M 13.37M 173M 13.45M 13.15M 573M | 357M 3.76M 3.25M 3.05M 2.78M 5.23M 5.26M 36.11M 14.05M 182M 14.13M 13.83M 603M |
| Net income | 42.46M 447K 386K 363K 331K 622K 625K 4.29M 1.67M 21.6M 1.68M 1.64M 71.62M | 57.89M 610K 526K 495K 451K 848K 853K 5.85M 2.28M 29.45M 2.29M 2.24M 97.64M |
| Net Debt | -36.87M -389K -335K -315K -287K -540K -543K -3.73M -1.45M -18.76M -1.46M -1.43M -62.19M | -32.39M -341K -294K -277K -252K -474K -477K -3.27M -1.27M -16.48M -1.28M -1.25M -54.64M |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | ₹158.85 | 0.00% | 1 |
| 01/09/26 | ₹158.85 | +1.83% | 2,198 |
| 31/08/26 | ₹156.00 | 0.00% | 589 |
| 28/08/26 | ₹156.00 | +0.68% | 819 |
| 27/08/26 | ₹154.95 | +0.13% | 225 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
